{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T06:13:27Z","timestamp":1789625607433,"version":"build-2803163510"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"State Key Development Program of Basic Research of China","award":["2012CB917100"],"award-info":[{"award-number":["2012CB917100"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Immunol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12865-016-0167-7","type":"journal-article","created":{"date-parts":[[2016,9,20]],"date-time":"2016-09-20T01:52:19Z","timestamp":1474336339000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["Repeated cycles of 5-fluorouracil chemotherapy impaired anti-tumor functions of cytotoxic T cells in a CT26 tumor-bearing mouse model"],"prefix":"10.1186","volume":"17","author":[{"given":"Yanhong","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenling","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiru","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbo","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxia","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuren","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,20]]},"reference":[{"issue":"21","key":"167_CR1","doi-asserted-by":"crossref","first-page":"8643","DOI":"10.1158\/0008-5472.CAN-07-6611","volume":"68","author":"VT DeVita Jr","year":"2008","unstructured":"DeVita Jr VT, Chu E. A history of cancer chemotherapy. Cancer Res. 2008;68(21):8643\u201353.","journal-title":"Cancer Res"},{"issue":"4","key":"167_CR2","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3322\/caac.21149","volume":"62","author":"R Siegel","year":"2012","unstructured":"Siegel R, DeSantis C, Virgo K, Stein K, Mariotto A, Smith T, Cooper D, Gansler T, Lerro C, Fedewa S, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin. 2012;62(4):220\u201341.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"167_CR3","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.immuni.2013.06.014","volume":"39","author":"L Zitvogel","year":"2013","unstructured":"Zitvogel L, Galluzzi L, Smyth MJ, Kroemer G. Mechanism of action of conventional and targeted anticancer therapies: reinstating immunosurveillance. Immunity. 2013;39(1):74\u201388.","journal-title":"Immunity"},{"key":"167_CR4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev-immunol-032712-100008","volume":"31","author":"G Kroemer","year":"2013","unstructured":"Kroemer G, Galluzzi L, Kepp O, Zitvogel L. Immunogenic cell death in cancer therapy. Annu Rev Immunol. 2013;31:51\u201372.","journal-title":"Annu Rev Immunol"},{"issue":"9","key":"167_CR5","doi-asserted-by":"crossref","first-page":"e955691","DOI":"10.4161\/21624011.2014.955691","volume":"3","author":"O Kepp","year":"2014","unstructured":"Kepp O, Senovilla L, Vitale I, Vacchelli E, Adjemian S, Agostinis P, Apetoh L, Aranda F, Barnaba V, Bloy N, et al. Consensus guidelines for the detection of immunogenic cell death. Oncoimmunology. 2014;3(9):e955691.","journal-title":"Oncoimmunology"},{"issue":"4","key":"167_CR6","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.immuni.2013.03.003","volume":"38","author":"Y Ma","year":"2013","unstructured":"Ma Y, Adjemian S, Mattarollo SR, Yamazaki T, Aymeric L, Yang H, Portela Catani JP, Hannani D, Duret H, Steegh K, et al. Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells. Immunity. 2013;38(4):729\u201341.","journal-title":"Immunity"},{"issue":"14","key":"167_CR7","doi-asserted-by":"crossref","first-page":"4809","DOI":"10.1158\/0008-5472.CAN-11-0753","volume":"71","author":"SR Mattarollo","year":"2011","unstructured":"Mattarollo SR, Loi S, Duret H, Ma Y, Zitvogel L, Smyth MJ. Pivotal role of innate and adaptive immunity in anthracycline chemotherapy of established tumors. Cancer Res. 2011;71(14):4809\u201320.","journal-title":"Cancer Res"},{"issue":"1","key":"167_CR8","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1158\/0008-5472.CAN-12-2225","volume":"73","author":"CL Chang","year":"2013","unstructured":"Chang CL, Hsu YT, Wu CC, Lai YZ, Wang C, Yang YC, Wu TC, Hung CF. Dose-dense chemotherapy improves mechanisms of antitumor immune response. Cancer Res. 2013;73(1):119\u201327.","journal-title":"Cancer Res"},{"issue":"1","key":"167_CR9","doi-asserted-by":"crossref","first-page":"e27884","DOI":"10.4161\/onci.27884","volume":"3","author":"G Stoll","year":"2014","unstructured":"Stoll G, Enot D, Mlecnik B, Galon J, Zitvogel L, Kroemer G. Immune-related gene signatures predict the outcome of neoadjuvant chemotherapy. Oncoimmunology. 2014;3(1):e27884.","journal-title":"Oncoimmunology"},{"issue":"3","key":"167_CR10","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.stem.2009.01.006","volume":"4","author":"AT Hooper","year":"2009","unstructured":"Hooper AT, Butler JM, Nolan DJ, Kranz A, Iida K, Kobayashi M, Kopp HG, Shido K, Petit I, Yanger K, et al. Engraftment and reconstitution of hematopoiesis is dependent on VEGFR2-mediated regeneration of sinusoidal endothelial cells. Cell Stem Cell. 2009;4(3):263\u201374.","journal-title":"Cell Stem Cell"},{"issue":"9","key":"167_CR11","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1002\/1097-0142(20011101)92:9<2419::AID-CNCR1591>3.0.CO;2-K","volume":"92","author":"A Banfi","year":"2001","unstructured":"Banfi A, Podesta M, Fazzuoli L, Sertoli MR, Venturini M, Santini G, Cancedda R, Quarto R. High-dose chemotherapy shows a dose-dependent toxicity to bone marrow osteoprogenitors: a mechanism for post-bone marrow transplantation osteopenia. Cancer. 2001;92(9):2419\u201328.","journal-title":"Cancer"},{"issue":"12","key":"167_CR12","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/S0301-472X(00)00547-6","volume":"28","author":"SN Robinson","year":"2000","unstructured":"Robinson SN, Freedman AS, Neuberg DS, Nadler LM, Mauch PM. Loss of marrow reserve from dose-intensified chemotherapy results in impaired hematopoietic reconstitution after autologous transplantation: CD34(+), CD34(+) 38(\u2212), and week-6 CAFC assays predict poor engraftment. Exp Hematol. 2000;28(12):1325\u201333.","journal-title":"Exp Hematol"},{"issue":"1","key":"167_CR13","first-page":"33","volume":"41","author":"P Perseghin","year":"2009","unstructured":"Perseghin P, Terruzzi E, Dassi M, Baldini V, Parma M, Coluccia P, Accorsi P, Confalonieri G, Tavecchia L, Verga L, et al. Management of poor peripheral blood stem cell mobilization: incidence, predictive factors, alternative strategies and outcome. A retrospective analysis on 2177 patients from three major Italian institutions. Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis. 2009;41(1):33\u20137.","journal-title":"Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis"},{"issue":"6","key":"167_CR14","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/nm.3155","volume":"19","author":"D Lucas","year":"2013","unstructured":"Lucas D, Scheiermann C, Chow A, Kunisaki Y, Bruns I, Barrick C, Tessarollo L, Frenette PS. Chemotherapy-induced bone marrow nerve injury impairs hematopoietic regeneration. Nat Med. 2013;19(6):695\u2013703.","journal-title":"Nat Med"},{"issue":"12","key":"167_CR15","doi-asserted-by":"crossref","first-page":"6259","DOI":"10.4049\/jimmunol.1203539","volume":"190","author":"AJ Litterman","year":"2013","unstructured":"Litterman AJ, Zellmer DM, Grinnen KL, Hunt MA, Dudek AZ, Salazar AM, Ohlfest JR. Profound impairment of adaptive immune responses by alkylating chemotherapy. J Immunol. 2013;190(12):6259\u201368.","journal-title":"J Immunol"},{"issue":"4","key":"167_CR16","doi-asserted-by":"crossref","first-page":"dju057","DOI":"10.1093\/jnci\/dju057","volume":"106","author":"HK Sanoff","year":"2014","unstructured":"Sanoff HK, Deal AM, Krishnamurthy J, Torrice C, Dillon P, Sorrentino J, Ibrahim JG, Jolly TA, Williams G, Carey LA, et al. Effect of cytotoxic chemotherapy on markers of molecular age in patients with breast cancer. J Natl Cancer Inst. 2014;106(4):dju057.","journal-title":"J Natl Cancer Inst"},{"key":"167_CR17","doi-asserted-by":"crossref","first-page":"g1219","DOI":"10.1136\/bmj.g1219","volume":"348","author":"AA Wright","year":"2014","unstructured":"Wright AA, Zhang B, Keating NL, Weeks JC, Prigerson HG. Associations between palliative chemotherapy and adult cancer patients\u2019 end of life care and place of death: prospective cohort study. BMJ. 2014;348:g1219.","journal-title":"BMJ"},{"issue":"6","key":"167_CR18","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1001\/jamaoncol.2015.2378","volume":"1","author":"HG Prigerson","year":"2015","unstructured":"Prigerson HG, Bao Y, Shah MA, Paulk ME, LeBlanc TW, Schneider BJ, Garrido MM, Reid MC, Berlin DA, Adelson KB, et al. Chemotherapy Use, Performance Status, and Quality of Life at the End of Life. JAMA oncology. 2015;1(6):778\u201384.","journal-title":"JAMA oncology"},{"key":"167_CR19","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/1741-7015-10-172","volume":"10","author":"Q Sun","year":"2012","unstructured":"Sun Q, Zhong Y, Wu F, Zhou C, Wang D, Ma W, Zhang Y, Zhang S. Immunotherapy using slow-cycling tumor cells prolonged overall survival of tumor-bearing mice. BMC medicine. 2012;10:172.","journal-title":"BMC medicine"},{"issue":"8","key":"167_CR20","doi-asserted-by":"crossref","first-page":"5818","DOI":"10.18632\/oncotarget.3461","volume":"6","author":"H Wang","year":"2015","unstructured":"Wang H, Sun Q, Wu Y, Wang L, Zhou C, Ma W, Zhang Y, Wang S, Zhang S. Granzyme M expressed by tumor cells promotes chemoresistance and EMT in vitro and metastasis in vivo associated with STAT3 activation. Oncotarget. 2015;6(8):5818\u201331.","journal-title":"Oncotarget"},{"issue":"9","key":"167_CR21","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/nm.2890","volume":"18","author":"Y Sun","year":"2012","unstructured":"Sun Y, Campisi J, Higano C, Beer TM, Porter P, Coleman I, True L, Nelson PS. Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B. Nat Med. 2012;18(9):1359\u201368.","journal-title":"Nat Med"},{"issue":"8","key":"167_CR22","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1158\/0008-5472.CAN-09-3690","volume":"70","author":"J Vincent","year":"2010","unstructured":"Vincent J, Mignot G, Chalmin F, Ladoire S, Bruchard M, Chevriaux A, Martin F, Apetoh L, Rebe C, Ghiringhelli F. 5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell-dependent antitumor immunity. Cancer Res. 2010;70(8):3052\u201361.","journal-title":"Cancer Res"},{"issue":"10","key":"167_CR23","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.1182\/blood.V89.10.3700","volume":"89","author":"CL Mackall","year":"1997","unstructured":"Mackall CL, Fleisher TA, Brown MR, Andrich MP, Chen CC, Feuerstein IM, Magrath IT, Wexler LH, Dimitrov DS, Gress RE. Distinctions between CD8+ and CD4+ T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy. Blood. 1997;89(10):3700\u20137.","journal-title":"Blood"},{"issue":"7","key":"167_CR24","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1182\/blood.V84.7.2221.2221","volume":"84","author":"CL Mackall","year":"1994","unstructured":"Mackall CL, Fleisher TA, Brown MR, Magrath IT, Shad AT, Horowitz ME, Wexler LH, Adde MA, McClure LL, Gress RE. Lymphocyte depletion during treatment with intensive chemotherapy for cancer. Blood. 1994;84(7):2221\u20138.","journal-title":"Blood"},{"issue":"7550","key":"167_CR25","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nature14395","volume":"521","author":"S Shalapour","year":"2015","unstructured":"Shalapour S, Font-Burgada J, Di Caro G, Zhong Z, Sanchez-Lopez E, Dhar D, Willimsky G, Ammirante M, Strasner A, Hansel DE, et al. Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy. Nature. 2015;521(7550):94\u20138.","journal-title":"Nature"},{"issue":"4","key":"167_CR26","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.ccr.2012.02.017","volume":"21","author":"ES Nakasone","year":"2012","unstructured":"Nakasone ES, Askautrud HA, Kees T, Park JH, Plaks V, Ewald AJ, Fein M, Rasch MG, Tan YX, Qiu J, et al. Imaging tumor-stroma interactions during chemotherapy reveals contributions of the microenvironment to resistance. Cancer Cell. 2012;21(4):488\u2013503.","journal-title":"Cancer Cell"},{"issue":"4","key":"167_CR27","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1158\/2326-6066.CIR-14-0215","volume":"3","author":"R Winograd","year":"2015","unstructured":"Winograd R, Byrne KT, Evans RA, Odorizzi PM, Meyer AR, Bajor DL, Clendenin C, Stanger BZ, Furth EE, Wherry EJ, et al. Induction of T-cell Immunity Overcomes Complete Resistance to PD-1 and CTLA-4 Blockade and Improves Survival in Pancreatic Carcinoma. Cancer immunology research. 2015;3(4):399\u2013411.","journal-title":"Cancer immunology research"},{"issue":"5","key":"167_CR28","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1172\/JCI30740","volume":"117","author":"S Biswas","year":"2007","unstructured":"Biswas S, Guix M, Rinehart C, Dugger TC, Chytil A, Moses HL, Freeman ML, Arteaga CL. Inhibition of TGF-beta with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression. J Clin Invest. 2007;117(5):1305\u201313.","journal-title":"J Clin Invest"},{"issue":"3","key":"167_CR29","doi-asserted-by":"crossref","first-page":"e23139","DOI":"10.4161\/onci.23139","volume":"2","author":"F Ghiringhelli","year":"2013","unstructured":"Ghiringhelli F, Bruchard M, Apetoh L. Immune effects of 5-fluorouracil: Ambivalence matters. Oncoimmunology. 2013;2(3):e23139.","journal-title":"Oncoimmunology"},{"key":"167_CR30","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejps.2015.10.001","volume":"81","author":"JA Duley","year":"2016","unstructured":"Duley JA, Ni M, Shannon C, Norris RL, Sheffield L, Harris M, van Kuilenburg AB, Mead S, Cameron A, Helsby N, et al. Towards a test to predict 5-fluorouracil toxicity: Pharmacokinetic data for thymine and two sequential metabolites following oral thymine administration to healthy adult males. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences. 2016;81:36\u201341.","journal-title":"European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences"},{"issue":"1","key":"167_CR31","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nm.2999","volume":"19","author":"M Bruchard","year":"2013","unstructured":"Bruchard M, Mignot G, Derangere V, Chalmin F, Chevriaux A, Vegran F, Boireau W, Simon B, Ryffel B, Connat JL, et al. Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth. Nat Med. 2013;19(1):57\u201364.","journal-title":"Nat Med"},{"issue":"6","key":"167_CR32","doi-asserted-by":"crossref","first-page":"e67904","DOI":"10.1371\/journal.pone.0067904","volume":"8","author":"SM Geary","year":"2013","unstructured":"Geary SM, Lemke CD, Lubaroff DM, Salem AK. The combination of a low-dose chemotherapeutic agent, 5-fluorouracil, and an adenoviral tumor vaccine has a synergistic benefit on survival in a tumor model system. PloS one. 2013;8(6):e67904.","journal-title":"PloS one"},{"issue":"19","key":"167_CR33","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/jnci\/dji188","volume":"97","author":"P Correale","year":"2005","unstructured":"Correale P, Del Vecchio MT, Di Genova G, Savellini GG, La Placa M, Terrosi C, Vestri M, Urso R, Lemonnier F, Aquino A, et al. 5-fluorouracil-based chemotherapy enhances the antitumor activity of a thymidylate synthase-directed polyepitopic peptide vaccine. J Natl Cancer Inst. 2005;97(19):1437\u201345.","journal-title":"J Natl Cancer Inst"},{"issue":"Suppl 8","key":"167_CR34","doi-asserted-by":"crossref","first-page":"viii6","DOI":"10.1093\/annonc\/mds256","volume":"23","author":"OJ Finn","year":"2012","unstructured":"Finn OJ. Immuno-oncology: understanding the function and dysfunction of the immune system in cancer. Annals of oncology : official journal of the European Society for Medical Oncology\/ESMO. 2012;23 Suppl 8:viii6\u20139.","journal-title":"Annals of oncology : official journal of the European Society for Medical Oncology\/ESMO"},{"issue":"6","key":"167_CR35","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1172\/JCI35180","volume":"118","author":"L Zitvogel","year":"2008","unstructured":"Zitvogel L, Apetoh L, Ghiringhelli F, Andre F, Tesniere A, Kroemer G. The anticancer immune response: indispensable for therapeutic success? J Clin Invest. 2008;118(6):1991\u20132001.","journal-title":"J Clin Invest"},{"issue":"1","key":"167_CR36","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1634\/stemcells.18-1-10","volume":"18","author":"CL Mackall","year":"2000","unstructured":"Mackall CL. T-cell immunodeficiency following cytotoxic antineoplastic therapy: a review. Stem Cells. 2000;18(1):10\u201318.","journal-title":"Stem Cells"},{"issue":"2","key":"167_CR37","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1365-2141.2010.08478.x","volume":"152","author":"CM Tilburg van","year":"2011","unstructured":"van Tilburg CM, van Gent R, Bierings MB, Otto SA, Sanders EA, Nibbelke EE, Gaiser JF, Janssens-Korpela PL, Wolfs TF, Bloem AC, et al. Immune reconstitution in children following chemotherapy for haematological malignancies: a long-term follow-up. Br J Haematol. 2011;152(2):201\u201310.","journal-title":"Br J Haematol"},{"issue":"8","key":"167_CR38","doi-asserted-by":"crossref","first-page":"e0135599","DOI":"10.1371\/journal.pone.0135599","volume":"10","author":"DL Chan","year":"2015","unstructured":"Chan DL, Pavlakis N, Shapiro J, Price TJ, Karapetis CS, Tebbutt NC, Segelov E. Does the Chemotherapy Backbone Impact on the Efficacy of Targeted Agents in Metastatic Colorectal Cancer? A Systematic Review and Meta-Analysis of the Literature. PloS one. 2015;10(8):e0135599.","journal-title":"PloS one"},{"issue":"10","key":"167_CR39","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1093\/annonc\/mdv286","volume":"26","author":"E Cutsem Van","year":"2015","unstructured":"Van Cutsem E, Prenen H, D\u2019Haens G, Bennouna J, Carrato A, Ducreux M, Bouche O, Sobrero A, Latini L, Staines H, et al. A phase I\/II, open-label, randomised study of nintedanib plus mFOLFOX6 versus bevacizumab plus mFOLFOX6 in first-line metastatic colorectal cancer patients. Annals of oncology : official journal of the European Society for Medical Oncology\/ESMO. 2015;26(10):2085\u201391.","journal-title":"Annals of oncology : official journal of the European Society for Medical Oncology\/ESMO"},{"issue":"6","key":"167_CR40","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1182\/blood-2007-06-092817","volume":"112","author":"R Nishimura","year":"2008","unstructured":"Nishimura R, Baker J, Beilhack A, Zeiser R, Olson JA, Sega EI, Karimi M, Negrin RS. In vivo trafficking and survival of cytokine-induced killer cells resulting in minimal GVHD with retention of antitumor activity. Blood. 2008;112(6):2563\u201374.","journal-title":"Blood"},{"issue":"23","key":"167_CR41","doi-asserted-by":"crossref","first-page":"5811","DOI":"10.1182\/blood-2009-02-203141","volume":"113","author":"S Yao","year":"2009","unstructured":"Yao S, Wang S, Zhu Y, Luo L, Zhu G, Flies S, Xu H, Ruff W, Broadwater M, Choi IH, et al. PD-1 on dendritic cells impedes innate immunity against bacterial infection. Blood. 2009;113(23):5811\u20138.","journal-title":"Blood"}],"container-title":["BMC Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-016-0167-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T04:15:30Z","timestamp":1601093730000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcimmunol.biomedcentral.com\/articles\/10.1186\/s12865-016-0167-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,20]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["167"],"URL":"https:\/\/doi.org\/10.1186\/s12865-016-0167-7","relation":{},"ISSN":["1471-2172"],"issn-type":[{"value":"1471-2172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,20]]},"article-number":"29"}}